Market News AIOpen the app

Haemonetics shares reach their highest price in a year after a big deal with CSL Plasma.

DealRead the original at Benzinga
Good for HAE

The planned move across CSL Plasma’s U.S. centers could increase device use and repeat disposable-product sales. The rollout remains unfinished and sales depend on orders, timing, and supply, but the broad planned reach makes the news positive.

HAE · Haemonetics Corporation

AI read · Good for HAE

The AI's read

A wider CSL network could mean more use of Haemonetics’ devices and repeat sales of disposable products. The plan is not final, and the company has not shared how much money it may bring. Sales will depend on CSL’s order amounts, rollout timing, and Haemonetics’ ability to supply.

Get alerts for HAE

Follow Haemonetics Corporation (HAE) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for HAE
Free on the App Store and Google Play, or on the web.